VIENNA, Va., March 17 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION has asked the American Stock Exchange (“AMEX”) for additional time to file its 10-K for the year ending September 30, 2005. CEL-SCI had previously indicated that it planned to file the 10-K by March 20, 2006 and the Company’s quarterly report for the period ending December 31, 2005 by April 6, 2006. The reasons for not being able to file the 10-K on time are described in the Company’s press release dated January 18, 2006.
CEL-SCI believes that, barring unforeseen circumstances, it will be able to file the 10-K for the year ending September 30, 2005 during the week of March 27, 2006. If that is the case, CEL-SCI still plans to file its quarterly report (10-Q) for the period ending December 31, 2005 by April 6, 2006.
Geert Kersten, Chief Executive of CEL-SCI, said, “We have been working with three accounting firms to finalize these financial statements by March 20, 2006, but the issues involving FAS 133 and EITF 00-19 are extremely complex and time consuming. Our primary goal has to be that we get it right and, despite a massive effort by all parties involved, this delay for the 10-K is simply unavoidable.”
CEL-SCI Corporation is developing new immune system based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland.
When used in this report, the words “intends,” “plans,” “believes,” “anticipated” and “expects” and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties, which could cause actual results to differ materially from those projected. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements, which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
CEL-SCI Corporation
CONTACT: Company Contact: Gavin de Windt of CEL-SCI Corporation,+1-703-506-9460; Investor Relations: Mike Lucci of Lucci Financial Group,LLC, +1-248-723-3330, for CEL-SCI Corporation
Web site: http://www.cel-sci.com/
